[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cancer Biomarker Market Size, Status and Forecast 2025

January 2018 | 101 pages | ID: GD332199EB9EN
QYResearch

US$ 3,300.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Cancer Biomarker market, analyzes and researches the Cancer Biomarker development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
  • Abbott Laboratories
  • F.Hoffmann-La Roche Ltd.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Affymetrix Inc.
  • Illumina, Inc.
  • Agilent Technologies
  • Merck & Co. Inc.
  • Hologic, Inc.
  • Sino Biological Inc.
  • Becton, Dickinson and Company
Market segment by Regions/Countries, this report covers
  • United States
  • EU
  • Japan
  • China
  • India
  • Southeast Asia
Market segment by Type, the product can be split into
  • Genetic Biomarkers
  • Epigenetic Biomarkers
  • Metabolic Biomarkers
  • Proteomic Biomarkers
  • Others
Market segment by Application, Cancer Biomarker can be split into
  • Drug discovery and Development
  • Diagnostics
  • Personalized medicine
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Cancer Biomarker Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF CANCER BIOMARKER

1.1 Cancer Biomarker Market Overview
  1.1.1 Cancer Biomarker Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Cancer Biomarker Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Cancer Biomarker Market by Type
  1.3.1 Genetic Biomarkers
  1.3.2 Epigenetic Biomarkers
  1.3.3 Metabolic Biomarkers
  1.3.4 Proteomic Biomarkers
  1.3.5 Others
1.4 Cancer Biomarker Market by End Users/Application
  1.4.1 Drug discovery and Development
  1.4.2 Diagnostics
  1.4.3 Personalized medicine
  1.4.4 Others

2 GLOBAL CANCER BIOMARKER COMPETITION ANALYSIS BY PLAYERS

2.1 Cancer Biomarker Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Abbott Laboratories
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Cancer Biomarker Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 F.Hoffmann-La Roche Ltd.
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Cancer Biomarker Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 QIAGEN
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Cancer Biomarker Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 Thermo Fisher Scientific Inc.
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Cancer Biomarker Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 Affymetrix Inc.
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Cancer Biomarker Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 Illumina, Inc.
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Cancer Biomarker Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments
3.7 Agilent Technologies
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Cancer Biomarker Revenue (Million USD) (2013-2018)
  3.7.5 Recent Developments
3.8 Merck & Co. Inc.
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Cancer Biomarker Revenue (Million USD) (2013-2018)
  3.8.5 Recent Developments
3.9 Hologic, Inc.
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Cancer Biomarker Revenue (Million USD) (2013-2018)
  3.9.5 Recent Developments
3.10 Sino Biological Inc.
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Cancer Biomarker Revenue (Million USD) (2013-2018)
  3.10.5 Recent Developments
3.11 Becton, Dickinson and Company

4 GLOBAL CANCER BIOMARKER MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Cancer Biomarker Market Size by Type (2013-2018)
4.2 Global Cancer Biomarker Market Size by Application (2013-2018)
4.3 Potential Application of Cancer Biomarker in Future
4.4 Top Consumer/End Users of Cancer Biomarker

5 UNITED STATES CANCER BIOMARKER DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Cancer Biomarker Market Size (2013-2018)
5.2 United States Cancer Biomarker Market Size and Market Share by Players (2013-2018)
5.3 United States Cancer Biomarker Market Size by Application (2013-2018)

6 EU CANCER BIOMARKER DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Cancer Biomarker Market Size (2013-2018)
6.2 EU Cancer Biomarker Market Size and Market Share by Players (2013-2018)
6.3 EU Cancer Biomarker Market Size by Application (2013-2018)

7 JAPAN CANCER BIOMARKER DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Cancer Biomarker Market Size (2013-2018)
7.2 Japan Cancer Biomarker Market Size and Market Share by Players (2013-2018)
7.3 Japan Cancer Biomarker Market Size by Application (2013-2018)

8 CHINA CANCER BIOMARKER DEVELOPMENT STATUS AND OUTLOOK

8.1 China Cancer Biomarker Market Size (2013-2018)
8.2 China Cancer Biomarker Market Size and Market Share by Players (2013-2018)
8.3 China Cancer Biomarker Market Size by Application (2013-2018)

9 INDIA CANCER BIOMARKER DEVELOPMENT STATUS AND OUTLOOK

9.1 India Cancer Biomarker Market Size (2013-2018)
9.2 India Cancer Biomarker Market Size and Market Share by Players (2013-2018)
9.3 India Cancer Biomarker Market Size by Application (2013-2018)

10 SOUTHEAST ASIA CANCER BIOMARKER DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Cancer Biomarker Market Size (2013-2018)
10.2 Southeast Asia Cancer Biomarker Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Cancer Biomarker Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Cancer Biomarker Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Cancer Biomarker Revenue and Growth Rate (2018-2025)
  11.1.2 EU Cancer Biomarker Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Cancer Biomarker Revenue and Growth Rate (2018-2025)
  11.1.4 China Cancer Biomarker Revenue and Growth Rate (2018-2025)
  11.1.5 India Cancer Biomarker Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Cancer Biomarker Revenue and Growth Rate (2018-2025)
11.2 Global Cancer Biomarker Market Size (Value) by Type (2018-2025)
11.3 Global Cancer Biomarker Market Size by Application (2018-2025)

12 CANCER BIOMARKER MARKET DYNAMICS

12.1 Cancer Biomarker Market Opportunities
12.2 Cancer Biomarker Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Cancer Biomarker Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Cancer Biomarker Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Global Cancer Biomarker Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Cancer Biomarker Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Cancer Biomarker Market Share by Regions (2013-2018)
Figure United States Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Cancer Biomarker Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Cancer Biomarker Revenue Market Share by Type in 2017
Figure Genetic Biomarkers Market Size (Million USD) and Growth Rate (2013-2018)
Figure Epigenetic Biomarkers Market Size (Million USD) and Growth Rate (2013-2018)
Figure Metabolic Biomarkers Market Size (Million USD) and Growth Rate (2013-2018)
Figure Proteomic Biomarkers Market Size (Million USD) and Growth Rate (2013-2018)
Figure Others Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Cancer Biomarker Market Share by Application in 2017
Figure Cancer Biomarker Market Size (Million USD) and Growth Rate in Drug discovery and Development (2013-2018)
Figure Cancer Biomarker Market Size (Million USD) and Growth Rate in Diagnostics (2013-2018)
Figure Cancer Biomarker Market Size (Million USD) and Growth Rate in Personalized medicine (2013-2018)
Figure Cancer Biomarker Market Size (Million USD) and Growth Rate in Others (2013-2018)
Table Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
Figure Cancer Biomarker Market Size Share by Players in 2013
Figure Cancer Biomarker Market Size Share by Players in 2017
Table Abbott Laboratories Basic Information List
Table Cancer Biomarker Business Revenue (Million USD) of Abbott Laboratories (2013-2018)
Figure Abbott Laboratories Cancer Biomarker Business Revenue Market Share (2013-2018)
Table F.Hoffmann-La Roche Ltd. Basic Information List
Table Cancer Biomarker Business Revenue (Million USD) of F.Hoffmann-La Roche Ltd. (2013-2018)
Figure F.Hoffmann-La Roche Ltd. Cancer Biomarker Business Revenue Market Share (2013-2018)
Table QIAGEN Basic Information List
Table Cancer Biomarker Business Revenue (Million USD) of QIAGEN (2013-2018)
Figure QIAGEN Cancer Biomarker Business Revenue Market Share (2013-2018)
Table Thermo Fisher Scientific Inc. Basic Information List
Table Cancer Biomarker Business Revenue (Million USD) of Thermo Fisher Scientific Inc. (2013-2018)
Figure Thermo Fisher Scientific Inc. Cancer Biomarker Business Revenue Market Share (2013-2018)
Table Affymetrix Inc. Basic Information List
Table Cancer Biomarker Business Revenue (Million USD) of Affymetrix Inc. (2013-2018)
Figure Affymetrix Inc. Cancer Biomarker Business Revenue Market Share (2013-2018)
Table Illumina, Inc. Basic Information List
Table Cancer Biomarker Business Revenue (Million USD) of Illumina, Inc. (2013-2018)
Figure Illumina, Inc. Cancer Biomarker Business Revenue Market Share (2013-2018)
Table Agilent Technologies Basic Information List
Table Cancer Biomarker Business Revenue (Million USD) of Agilent Technologies (2013-2018)
Figure Agilent Technologies Cancer Biomarker Business Revenue Market Share (2013-2018)
Table Merck & Co. Inc. Basic Information List
Table Cancer Biomarker Business Revenue (Million USD) of Merck & Co. Inc. (2013-2018)
Figure Merck & Co. Inc. Cancer Biomarker Business Revenue Market Share (2013-2018)
Table Hologic, Inc. Basic Information List
Table Cancer Biomarker Business Revenue (Million USD) of Hologic, Inc. (2013-2018)
Figure Hologic, Inc. Cancer Biomarker Business Revenue Market Share (2013-2018)
Table Sino Biological Inc. Basic Information List
Table Cancer Biomarker Business Revenue (Million USD) of Sino Biological Inc. (2013-2018)
Figure Sino Biological Inc. Cancer Biomarker Business Revenue Market Share (2013-2018)
Table Becton, Dickinson and Company Basic Information List
Table Cancer Biomarker Business Revenue (Million USD) of Becton, Dickinson and Company (2013-2018)
Figure Becton, Dickinson and Company Cancer Biomarker Business Revenue Market Share (2013-2018)
Table Global Cancer Biomarker Market Size (Million USD) by Product (2013-2018)
Figure Global Cancer Biomarker Revenue Market Share (%) by Product (2013-2018)
Figure Global Cancer Biomarker Market Share by Product in 2017
Table Global Cancer Biomarker Market Size by Application (2013-2018)
Figure Global Cancer Biomarker Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Cancer Biomarker
Figure United States Cancer Biomarker Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
Figure United States Cancer Biomarker Market Size Share by Players in 2013
Figure United States Cancer Biomarker Market Size Share by Players in 2017
Table United States Cancer Biomarker Market Size by Application (2013-2018)
Figure United States Cancer Biomarker Revenue Market Share (%) by Application (2013-2018)
Figure United States Cancer Biomarker Market Size Share by Application in 2017
Figure EU Cancer Biomarker Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
Figure EU Cancer Biomarker Market Size Share by Players in 2013
Figure EU Cancer Biomarker Market Size Share by Players in 2017
Table EU Cancer Biomarker Market Size by Application (2013-2018)
Figure EU Cancer Biomarker Revenue Market Share (%) by Application (2013-2018)
Figure EU Cancer Biomarker Market Size Share by Application in 2017
Figure Japan Cancer Biomarker Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
Figure Japan Cancer Biomarker Market Size Share by Players in 2013
Figure Japan Cancer Biomarker Market Size Share by Players in 2017
Table Japan Cancer Biomarker Market Size by Application (2013-2018)
Figure Japan Cancer Biomarker Revenue Market Share (%) by Application (2013-2018)
Figure Japan Cancer Biomarker Market Size Share by Application in 2017
Figure China Cancer Biomarker Market Size (Million USD) and Growth Rate (2013-2018)
Table China Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
Figure China Cancer Biomarker Market Size Share by Players in 2013
Figure China Cancer Biomarker Market Size Share by Players in 2017
Table China Cancer Biomarker Market Size by Application (2013-2018)
Figure China Cancer Biomarker Revenue Market Share (%) by Application (2013-2018)
Figure China Cancer Biomarker Market Size Share by Application in 2017
Figure India Cancer Biomarker Market Size (Million USD) and Growth Rate (2013-2018)
Table India Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
Figure India Cancer Biomarker Market Size Share by Players in 2013
Figure India Cancer Biomarker Market Size Share by Players in 2017
Table India Cancer Biomarker Market Size by Application (2013-2018)
Figure India Cancer Biomarker Revenue Market Share (%) by Application (2013-2018)
Figure India Cancer Biomarker Market Size Share by Application in 2017
Figure Southeast Asia Cancer Biomarker Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Cancer Biomarker Market Size Share by Players in 2013
Figure Southeast Asia Cancer Biomarker Market Size Share by Players in 2017
Table Southeast Asia Cancer Biomarker Market Size by Application (2013-2018)
Figure Southeast Asia Cancer Biomarker Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Cancer Biomarker Market Size Share by Application in 2017
Figure Global Cancer Biomarker Market Size and Growth Rate (2018-2025)
Table Global Cancer Biomarker Market Size (Million USD) by Regions (2018-2025)
Figure Global Cancer Biomarker Market Size Share (2018-2025)
Figure Global Cancer Biomarker Market Size Share by Regions in 2025
Figure United States Cancer Biomarker Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Cancer Biomarker Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Cancer Biomarker Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Cancer Biomarker Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Cancer Biomarker Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Cancer Biomarker Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Cancer Biomarker Market Size (Million USD) by Type (2018-2025)
Figure Global Cancer Biomarker Market Size Share by Type in 2018
Figure Global Cancer Biomarker Market Size Share by Type in 2025
Table Global Cancer Biomarker Market Size (Million USD) by Application (2018-2025)
Figure Global Cancer Biomarker Market Size (Million USD) by Application in 2018
Figure Global Cancer Biomarker Market Size (Million USD) by Application in 2025


More Publications